Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Healthcare Revolution 2024: Largest Industry Event Moves to Drive Superior Results in Healthcare and Medical Tourism 2024-04-11 23:36
Don't Miss Out - Join the 7th IFPA Conference: Uncovering the Broad Spectrum of Psoriatic Disease 2024-04-11 16:00
Nanoform Enters Exclusive Partnership with CBC to Bring Best-in-Class Nanomedicine Technology to Japan 2024-04-11 15:38
Nuevocor Strengthens Leadership Team with Appointment of John Lee as Chief Medical Officer 2024-04-11 14:59
J INTS BIO, AACR 2024 - 'JIN-A02', a Novel Oral 4th Generation EGFR TKI, showing Clinical Benefits in the Ongoing Phase 1 Study 2024-04-11 14:56
CSafe unveils cutting-edge innovations to meet cold chain customer needs 2024-04-10 22:50
ACROBiosystems Launches 3D Organoid Solutions, Propelling New Frontiers in Biotherapeutic Research 2024-04-10 21:00
3Shape Charts Sustainable Course with Release of Comprehensive Sustainability Report 2023 2024-04-10 18:29
Leading the Way: Nicklaus Children's Hospital Awarded Global Healthcare Accreditation with Excellence for Pediatric Medical Travel Services 2024-04-10 18:00
Tsingke Showcases Cutting-Edge Biologics Solutions at Biologics 2024 2024-04-10 14:19
ACROBiosystems Launches 3D Organoid Solutions, Propelling New Frontiers in Biotherapeutic Research 2024-04-10 14:05
R&D Progress: Enrollment of Subjects in Phase III Clinical Trial for Inhaled Aerosol Drug in Children by Kexing Biopharm 2024-04-10 11:41
Alphamab Oncology Presented the Dose-escalation Results from JSKN003 in Patients with Advanced/Metastatic Solid Tumors at AACR 2024-04-10 08:40
Neoss Integrate Australia 2024 - Integrate. Educate. Celebrate 2024-04-09 23:24
The Second International Conference on Single-cell and Spatial Omics (TICSSO-2) : showcasing the state-of-the-art bioscience achievements 2024-04-09 23:14
BioCity Announces FDA Clearance of the Investigational New Drug Application for its First-In-Class Antibody Drug Conjugate Targeting Glypican 3 2024-04-09 22:10
Datasea Announces Intent of its CEO to Purchase Up $3,000,000 of its Common Stock in Open Market Purchases 2024-04-09 22:00
YS Biopharma Announces Positive Interim Results of Pivotal Phase 3 Clinical Study of PIKA Rabies Vaccine 2024-04-09 20:00
Jacobio Pharma to Present Data of PARP7 Inhibitor and P53 Reactivator at the 2024 AACR Annual Meeting 2024-04-09 19:59
GenFleet Therapeutics Announces Broad-spectrum Activity of GFH547, an Oral panRAS (ON) Inhibitor, and Its Potential to Overcome Resistance against SIIP-based KRAS Inhibitors in Late-breaking Research Abstract of 2024 AACR Annual Meeting 2024-04-09 19:00
1 76 77 78 79 80 962